These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 36538901)

  • 1. Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma.
    Magliocca KR; Kaka AS; Barrow EM; Studer MB; Griffith CC; Ernst J; Meade T; Balicki A; Boyce BJ; Schmitt NC; Bur AM; Schmitt AC; Jackson R; Steuer CE; Beitler JJ; Patel MR
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):80-87. PubMed ID: 36538901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Intraoperative Frozen Section Controls With Improved Margin Assessment During Transoral Robotic Surgery for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
    Yu AC; Afework DD; Goldstein JD; Abemayor E; Mendelsohn AH
    JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1029-1037. PubMed ID: 36136328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
    Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
    J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma.
    Holcomb AJ; Herberg M; Strohl M; Ochoa E; Feng AL; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Sadow P; Faquin W; Faden D; Deschler DG; Varvares MA; Lin DT; Fakhry C; Ryan WR; Richmon JD
    Head Neck; 2021 Aug; 43(8):2434-2444. PubMed ID: 33856083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232
    [No Abstract]   [Full Text] [Related]  

  • 6. Positive Deep Initial Incision Margin Affects Outcomes in TORS for HPV+ Oropharynx Cancer.
    Kejner A; Gentile C; Porterfield Z; Carroll WR; Buczek EP
    Laryngoscope; 2023 May; 133(5):1132-1137. PubMed ID: 35809041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
    Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
    Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
    Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
    Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Margins by Oropharyngeal Subsite in Transoral Robotic Surgery for T1/T2 Squamous Cell Carcinoma.
    Persky MJ; Albergotti WG; Rath TJ; Kubik MW; Abberbock S; Geltzeiler M; Kim S; Duvvuri U; Ferris RL
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):660-666. PubMed ID: 29182490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
    Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.
    Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma.
    Frederiksen JG; Channir HI; Larsen MHH; Christensen A; Friborg J; Charabi BW; Rubek N; von Buchwald C
    Acta Otolaryngol; 2021 Jul; 141(7):714-718. PubMed ID: 34191671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes.
    Warner L; O'Hara JT; Lin DJ; Oozeer N; Fox H; Meikle D; Hamilton D; Iqbal MS; Robinson M; Paleri V
    Oral Oncol; 2022 Jul; 130():105909. PubMed ID: 35636080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
    Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
    JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
    Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
    Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV/p16-positive oropharyngeal cancer treated with transoral robotic surgery: The roles of margins, extra-nodal extension and adjuvant treatment.
    Nichols DS; Zhao J; Boyce BJ; Amdur R; Mendenhall WM; Danan D; Hitchcock K; Ning K; Keyes K; Lee JH; Dziegielewski PT
    Am J Otolaryngol; 2021; 42(1):102793. PubMed ID: 33130532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
    Mahmoud O; Sung K; Civantos FJ; Thomas GR; Samuels MA
    Head Neck; 2018 Apr; 40(4):710-721. PubMed ID: 29244238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes.
    Moore EJ; Van Abel KM; Price DL; Lohse CM; Olsen KD; Jackson RS; Martin EJ
    Head Neck; 2018 Apr; 40(4):747-755. PubMed ID: 29327784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.